![]() ![]() The aim of our study was to estimate the resource use associated with MRSA in Norwegian hospitals in terms of length of stay, readmissions within 30 days and DRG-based costs, in order to provide a better knowledge base for infection prevention strategies. To our best knowledge, there are currently no studies estimating the economic impact of MRSA positive patients based on LOS, readmissions or DRG costs in Norwegian hospitals. Some studies have explored the cost-effectiveness of drugs used to treat MRSA infections and costs related to MRSA screening in Norway. The current MRSA-strategy in Norwegian hospitals consists of isolating suspected and confirmed MRSA positive patients, work restrictions for healthcare personnel who test positive for MRSA, and decolonization of carriers. The spread of MRSAin Norwegian hospitals is controlled through screening routines, which consist of testing patients before admission if they have previously tested positive or are suspected of having been exposed to MRSA in the 12 months prior. aureus isolates in Norway that were methicillin-resistant was only 1.3% in 2012, and Norway is considered to be amongst the European countries with the lowest percentage of MRSA in S. In Norway, all diagnosed cases of MRSA are mandatorily notified to the Norwegian Surveillance System for Communicable Diseases (MSIS). It is however associated with several types of illnesses, most commonly skin and soft tissue infections, although it may also cause more severe infections. ![]() The bacterium is a normal inhabitant in the human body, found persistent on the skin or mucosa of 20% of adults. Staphylococcus aureus is considered to be one of the most common pathogens causing nosocomial infections. The results of this study indicate that Norwegian patients with MRSA have longer hospital stays, and higher costs than those without MRSA. DRG based hospital costs were 0.37 (95% CI, 0.19–0.54) times higher among cases than controls, with a mean cost of EUR13,233(SD 26,899) and EUR7198(SD 18,159) respectively. However, the risk of readmission was not significantly higher for patients with MRSA. Norwegian patients with MRSA stayed on average 8 days longer in hospital than controls, corresponding to a ratio of mean duration of 2.08 (CI 95%, 1.75–2.47) times longer.A total of 14% of MRSA positive inpatients were readmitted compared to 10% among controls. We used a matched case-control method to compare MRSA diagnosed inpatients with non-MRSA inpatients in terms of length of stay, readmissions within 30 days from discharge, as well as the Diagnosis-Related Group (DRG) based costs. MethodsĪnalyses were based on data fromSouth-Eastern Norway for the year 2012 as registered in the Norwegian Surveillance System for Communicable Diseases and the Norwegian Patient Registry. The aim of this study was to assess the costs associated with MRSA in Norwegian hospitals. aureus (MRSA) are thought to incur additional costs for hospitals due to longer stay and contact isolation. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |